×
BrightSpring Health Services EBITDA 2022-2024 | BTSG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
BrightSpring Health Services ebitda from 2022 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
BrightSpring Health Services EBITDA 2022-2024 | BTSG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
BrightSpring Health Services ebitda from 2022 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.8B
Avantor (AVTR)
$12B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
Surgery Partners (SGRY)
$3.3B
GeneDx Holdings (WGS)
$3.1B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B